UPDATE : Thursday, August 22, 2019
상단여백
Xeljianz is easier to use than biologic therapies -- is it safer, however? by Kim Yun-mi 2019-05-10 15:34
[Exclusive] MSD Korea playing tricks to reduce daycare cost by Kim Yun-mi 2019-05-09 11:20
[Reporter’s Notebook] Roche agreed, MSD and BMS should, too by Kim Yun-mi 2019-05-07 14:30
Leading hepatitis C drug wins FDA nod for adolescents by Kim Yun-mi 2019-05-03 15:51
New head of HUMC to put focus on research by Kim Yun-mi 2019-05-02 16:57
라인
‘MSD Korea’s monitoring program might be privacy breach’ by Kim Yun-mi 2019-05-02 11:00
Drugmakers brace for vaccine shortage amid surging hepatitis A cases by Kim Yun-mi 2019-04-30 13:13
Breast cancer society to focus on patients’ quality of life by Kim Yun-mi 2019-04-26 14:22
‘PD-L1 expression poor marker for bladder cancer’s immunotherapy’ by Kim Yun-mi 2019-04-25 11:52
[News Focus] Cholesterol-reducing PCSK9 inhibitors get popular -- cost-effective, too? by Kim Yun-mi 2019-04-24 12:35
라인
How to improve treatment guidelines for dyslipidemia? by Kim Yun-mi 2019-04-22 14:50
‘No need to reduce number of drugs for triple-drug therapy to treat HIV’ by Kim Yun-mi 2019-04-18 15:20
Novartis’ new macular degeneration drug has to compete against colon cancer drug Avastin. Why? by Kim Yun-mi 2019-04-18 14:42
Immunotherapies’ liver cancer-treating effects confirmed in real-world studies by Kim Yun-mi 2019-04-15 14:29
Doctors skeptical about GSK’s new HIV drug despite FDA nod by Kim Yun-mi 2019-04-11 13:55
라인
Saxenda no silver bullet for weight loss, doctors warn by Kim Yun-mi 2019-04-05 16:21
[Reporter’s Notebook] Concerns over TB risk rise amid more use of TNF-α inhibitors by Kim Yun-mi 2019-03-29 17:21
Korean women more prone to infection with HPV-52, 58 by Kim Yun-mi 2019-03-28 15:03
[Special] Interleukin inhibitors Cosentyx, Taltz target psoriasis market by Kim Yun-mi 2019-03-26 14:56
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials by Kim Yun-mi 2019-03-22 15:50
여백
여백
여백
Back to Top